Search Results - "Tokura, Momoko"

Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ by Tokura, Momoko, Nakayama, Jun, Prieto-Vila, Marta, Shiino, Sho, Yoshida, Masayuki, Yamamoto, Tomofumi, Watanabe, Naoaki, Takayama, Shin, Suzuki, Yutaka, Okamoto, Koji, Ochiya, Takahiro, Kohno, Takashi, Yatabe, Yasushi, Suto, Akihiko, Yamamoto, Yusuke

“…Abstract Ductal carcinoma in situ (DCIS) is a precursor to invasive breast cancer. The frequency of DCIS is increasing because of routine mammography; however,…”
Get full text

Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case by Omi, Yoko, Horiuchi, Kiyomi, Haniu, Kento, Tokura, Momoko, Nagai, Erin, Isozaki, Osamu, Nagashima, Yoji, Okamoto, Takahiro

“…Primary hyperparathyroidism is the most common hormonal manifestation associated with multiple endocrine neoplasia 1 (MEN1). It is generally caused by…”
Get full text

Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy by Watanabe, Sho, Shimoi, Tatsunori, Nishikawa, Tadaaki, Kawachi, Asuka, Okuma, Hitomi Sumiyoshi, Tokura, Momoko, Yazaki, Shu, Mizoguchi, Chiharu, Arakaki, Motoko, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Kojima, Yuki, Sudo, Kazuki, Noguchi, Emi, Yoshida, Akihiko, Kawai, Akira, Fujiwara, Yasuhiro, Yonemori, Kan

“…Prognostic value of hematologic indices and their association with the tumor microenvironment (TME) remain unclear in advanced soft tissue sarcoma (STS). We…”
Get full text

Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study by Takamizawa, Shigemasa, Shimoi, Tatsunori, Yoshida, Masayuki, Tokura, Momoko, Yazaki, Shu, Mizoguchi, Chiharu, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Kojima, Yuki, Sumiyoshi-Okuma, Hitomi, Nishikawa, Tadaaki, Noguchi, Emi, Sudo, Kazuki, Yonemori, Kan

“…Routine measurement of tumor markers is not recommended in daily clinical practice for patients with cancer of unknown primary (CUP). We evaluated the…”
Get full text

Investigation of Tumor Heterogeneity Using Integrated Single-Cell RNA Sequence Analysis to Focus on Genes Related to Breast Cancer-, EMT-, CSC-, and Metastasis-Related Markers in Patients with HER2-Positive Breast Cancer by Shiino, Sho, Tokura, Momoko, Nakayama, Jun, Yoshida, Masayuki, Suto, Akihiko, Yamamoto, Yusuke

“…Human epidermal growth factor receptor 2 (HER2) protein, which is characterized by the amplification of ERBB2, is a molecular target for HER2-overexpressing…”
Get full text

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer by Sanomachi, Tomomi, Okuma, Hitomi Sumiyoshi, Kitadai, Rui, Kawachi, Asuka, Yazaki, Shu, Tokura, Momoko, Arakaki, Motoko, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Maejima, Aiko, Kojima, Yuki, Nishikawa, Tadaaki, Sudo, Kazuki, Shimoi, Tatsunori, Noguchi, Emi, Fujiwara, Yasuhiro, Sugino, Hirokazu, Shiino, Sho, Suto, Akihiko, Yoshida, Masayuki, Yonemori, Kan

“…Triple-negative breast cancer (TNBC) is negative for hormone receptors and human epidermal growth factor receptor 2 (HER2). In stage I TNBC, adjuvant therapy…”
Get full text

Changes in HER3 expression profiles between primary and recurrent gynecological cancers by Kojima, Yuki, Sudo, Kazuki, Yoshida, Hiroshi, Yazaki, Shu, Tokura, Momoko, Mizoguchi, Chiharu, Okuma, Hitomi S, Kita, Shosuke, Yamamoto, Kasumi, Nishikawa, Tadaaki, Noguchi, Emi, Shimoi, Tatsunori, Tanase, Yasuhito, Uno, Masaya, Ishikawa, Mitsuya, Kato, Tomoyasu, Koyama, Kumiko, Kobayashi, Maki, Kakegawa, Tomoya, Fujiwara, Yasuhiro, Yonemori, Kan

“…Human epidermal growth factor receptor-3 (HER3) is a member of the epidermal growth factor receptor family of receptor tyrosine kinases, and its overexpression…”
Get full text

Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study by Tokura, Momoko, Ando, Mark Malalay, Kojima, Yuki, Kitadai, Rui, Yazaki, Shu, Atutubo, Cyrielle Marie N, Li, Rubi K., Perez, Minda Z., Gorospe, Agnes E, Madrid, Manuelito A, Ordinario, Mel Valerie C, Imasa, Marcelo Severino B, Sudo, Kazuki, Shimoi, Tatsunori, Suto, Akihiko, Kohsaka, Shinji, Machida, Ryunosuke, Sadachi, Ryo, Yoshida, Masayuki, Yatabe, Yasushi, Hata, Tomomi, Nakamura, Kenichi, Yonemori, Kan, Shiino, Sho

“…Background: Biomarkers to predict the recurrence risk are required to optimize perioperative treatment. Adjuvant chemotherapy for patients with human epidermal…”
Get full text

O12-5 A retrospective analysis of the clinical factors affecting the prognosis of non-seminomatous mediastinal germ cell tumor by Amano, Yosuke, Shimoi, Tatsunori, Tokura, Momoko, Mizoguchi, Chiharu, Kita, Shosuke, Yamamoto, Kasumi, Yazaki, Shu, Okuma, Hitomi, Kojima, Yuki, Nishikawa, Tadaaki, Noguchi, Emi, Sudo, Kazuki, Yonemori, Kan

Get full text

MO41-6 Trastuzumab-deruxtecan and blood inflammatory markers in HER2-positive metastatic breast cancer by Onishi, Mai, Shimoi, Tatsunori, Kitadai, Rui, Tokura, Momoko, Yazaki, Shu, Sumiyoshi-Okuma, Hitomi, Arakaki, Motoko, Saito, Ayumi, Kita, Syosuke, Yamamoto, Kasumi, Maejima, Aiko, Kojima, Yuki, Nishikawa, Tadaaki, Sudo, Kazuki, Noguchi, Emi, Fujiwara, Yasuhiro, Yonemori, Kan

Get full text

MO33-2 Retrospective analysis of urothelial carcinoma treated with enfortumab vedotin at our institution by Imai, Toru, Kita, Shosuke, Shimoi, Tatsunori, Yazaki, Shu, Tokura, Momoko, Kawachi, Asuka, Okuma, Hitomi S., Nakamura, Eijiro, Arakaki, Motoko, Saito, Ayumi, Yamamoto, Kasumi, Maejima, Aiko, Kojima, Yuki, Nishikawa, Tadaaki, Sudo, Kazuki, Noguchi, Emi, Matsui, Yoshiyuki, Fujiwara, Yasuhiro, Yonemori, Kan

Get full text

MO42-6 Analysis of sperm preservation in patients with mediastinal germ cell tumor patients by Umamoto, Kotaro, Saito, Ayumi, Noguchi, Emi, Takahashi, Yoshiko, Kitadai, Rui, Arakaki, Motoko, Yazaki, Shu, Tokura, Momoko, Kawachi, Asuka, Yamamoto, Kasumi, Kita, Shosuke, Kojima, Yuki, Maejima, Aiko, Nakamura, Eijiro, Nishikwa, Tadaaki, Shimoi, Tatsunori, Sudo, Kazuki, Yonemori, Kan

Get full text

MO9-1 Clinical characteristics of HER2-low stage I triple-negative breast cancer by Sanomachi, Tomomi, Shumiyoshi, Hitomi Okuma, Kitadai, Rui, Kawachi, Asuka, Yazaki, Shu, Tokura, Momoko, Arakaki, Motoko, Saito, Ayumi, Kita, Shosuke, Yamamoto, Kasumi, Maejima, Aiko, Kojima, Yuki, Nishikawa, Tadaaki, Sudo, Kazuki, Shimoi, Tatsunori, Noguchi, Emi, Fujiwara, Yasuhiro, Suto, Akihiko, Yonemori, Kan

Get full text

MO17-1 Clinical practice of comprehensive genomic profiling in gynecologic malignancies at National Cancer Center Hospital by Chiba, Yohei, Sudo, Kazuki, Arakaki, Motoko, Saito, Ayumi, Tokura, Momoko, Yazaki, Syu, Mizoguchi, Chiharu, Okuma, Hitomi, Kita, Syosuke, Yamamoto, Kasumi, Kojima, Yuki, Nishikawa, Tadaaki, Noguchi, Emi, Shimoi, Tatsunori, Yonemori, Kan

Get full text

P38-3 Clinical outcomes of next-generation sequencing test for breast cancer at the National Cancer Center Hospital by Nishimura, Rumi, Kazuki, Sudo, Arakaki, Motoko, Saitou, Ayumi, Chiba, Yohei, Tokura, Momoko, Mizoguchi, Chiharu, Kita, Shousuke, Yamamoto, Kasumi, Yazaki, Shu, Okuma, Hitomi, Kojima, Yuki, Nishikawa, Tadaaki, Noguchi, Emi, Shimoi, Tatsunori, Yonemori, Kan

Get full text

Folate receptor alpha expression is widely observed in uterine and ovarian carcinosarcoma (209) by Saito, Ayumi, Nishikawa, Tadaaki, Yoshida, Hiroshi, Mizoguchi, Chiharu, Shosuke, Kita, Tokura, Momoko, Yazaki, Shu, Kojima, Yuki, Yamamoto, Kasumi, Okuma, Hitomi, Noguchi, Emi, Sudo, Kazuki, Shimoi, Tatsunori, Kato, Mayumi, Tanase, Yasuhito, Uno, Masaya, Ishikawa, Mitsuya, Kato, Tomoyasu, Yonemori, Kan

Get full text

Abstract B063: Investigation of tumor heterogeneity using integrated single-cell RNA sequence data based on HER2 status in patients with breast cancer by Shiino, Sho, Tokura, Momoko, Nakayama, Jun, Yoshida, Masayuki, Suto, Akihiko, Yamamoto, Yusuke

“…Abstract [Introduction] Human epidermal growth factor receptor 2 (HER2), which is characterized by ERBB2 amplification, is one of the important markers for…”
Get full text

Abstract 975: Genomic landscape of circulating tumor DNA in cervical cancer in Asia: NCCH1905/A-TRAIN trial by Yehgambaram, Prathepamalar, Kojima, Yuki, Sudo, Kazuki, Yazaki, Shu, Tokura, Momoko, Ito, Munehiro, Hoshino, Mai, Fui, Wong Yoke, Voon, Pei Jye, Tan, David SP, Lertkhachonsuk, Arb-aroon, Pham, Anh Tuan, Quoc, Thinh Dang Huy, Ishak, Wan Zamaniah Wan, Yoshida, Hiroshi, Kohsaka, Shinji, Nagasaka, Yukari, Machida, Ryunosuke, Hata, Tomomi, Nakamura, Kenichi, Yonemori, Kan

“…Abstract Background: Cervical cancer is the second most common cancer among women worldwide, with over 500,000 new cases diagnosed annually and a 50% mortality…”
Get full text

Locally advanced triple negative breast cancer arising from fibroadenoma with complete response to neoadjuvant chemotherapy: A case report by Shiino, Sho, Yoshida, Masayuki, Tokura, Momoko, Watase, Chikashi, Murata, Takeshi, Jimbo, Kenjiro, Takayama, Shin, Suto, Akihiko, Satomi, Kaishi, Miyagi Maeshima, Akiko, Kikuchi, Mari, Uchiyama, Nachiko, Kinoshita, Takayuki

“…•Breast cancer arising in association with a fibroadenoma (FA) is rare and usually early-stage.•We report a rare case of an advanced triple negative breast…”
Get full text

Abstract 5083: Changes in HER3 expression profiles between initial diagnosis and recurrence in gynecologic cancers by Kojima, Yuki, Sudo, Kazuki, Yoshida, Hiroshi, Yazaki, Shu, Tokura, Momoko, Kita, Shosuke, Yamamoto, Kasumi, Mizoguchi, Chiharu, Okuma, Hitomi S, Nishikawa, Tadaaki, Noguchi, Emi, Shimoi, Tatsunori, Tanase, Yasuhito, Uno, Masaya, Ishikawa, Mitsuya, Kato, Tomoyasu, Koyama, Kumiko, Kobayashi, Maki, Kakegawa, Tomoya, Fujiwara, Yasuhiro, Yonemori, Kan

“…Abstract Background: HER3 (ErbB-3) is a member of the epidermal growth factor receptor family of receptor tyrosine kinases, and its overexpression is…”
Get full text